Medical Advocates
Ethics and Infectious Diseases
  Ethical Challenges
Screening/Testing
 Refusal of Care/Services
Detention
Patient Exploitation
Compulsory Treatment
Decision-Making
Reproduction
Transplants
End-of-Life Care
Enteral Nutrition
Professional Associations
National Challenges         Sterilization
Bioterrorism                     Prison Challenges
 HIV Exceptionalism           Conflicts of Interest
Pharmaceutical Industry   Pregnancy
HIV Prevention   
Stigma
 Physician Reimbursement 
Ethics and Disease Challenges and Duties
 HIV Cure
 Ebola Virus Disease
 Executions






 
Ethics Main Page Main New and Noteworthy Home Page

Outcome Studies
Adherence
Discontinuation of ARVs
ARVs and Vaginal Delivery
 ARVs and C-Sections
 Treatment of Neonates

 
HIV Pregnancy Main Page Women Main Page  
Last Update:  August 04, 2008
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
General Studies/Reports
 
           Journal Papers, Abstracts, and Commentaries
 
 
Increased mtDNA Levels Without Change in Mitochondrial Enzymes in Peripheral Blood Mononuclear
Cells of Infants Born to HIV-Infected Mothers on Antiretroviral Therapy.
 McComsey GA, Kang M, Ross AC, et al
HIV Clin Trials. 2008 Jan 1;9(2):126-136.
 Abstract

Immunologic features of HIV-1-infected women on HAART at delivery.
Ono E, Dos Santos AM, Machado DM, et al
Cytometry B Clin Cytom. 2008 Apr 7 ||
 Abstract
 
Effects of antiretroviral agents during pregnancy on liver enzymes and amylase in
HIV-exposed, uninfected newborn infants.
El Beitune P, Duarte G, Campbell O, et al
Braz J Infect Dis. 2007 Jun;11(3):314-7.
 Abstract
 
ARTICLE
Characteristics and management of HIV-1-infected pregnant women enrolled in a
randomised trial: differences between Europe and the USA.
Newell ML, Huang S, Fiore S, et al   
BMC Infect Dis. 2007 Jun 20;7(1):60
 Paper
 
A WEEK-IN-REVIEW FEATURED REPORT
Time to undetectable viral load after highly active antiretroviral therapy initiation among
HIV-infected pregnant women.
European Collaborative Study; Patel D, Cortina-Borja M, Thorne C, Newell ML.
Clin Infect Dis. 2007 Jun 15;44(12):1647-56.
 Abstract
 
AIDS in pregnancy, part II: Treatment in the era of highly active antiretroviral therapy
and management of obstetric, anesthetic, and pediatric issues.
Rigopoulos D, Gregoriou S, Paparizos V, Katsambas A.
Skinmed. 2007 Mar-Apr;6(2):79-84
 Abstract
 
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Volmink J, Siegfried N, van der Merwe L, Brocklehurst P.
Cochrane Database Syst Rev. 2007 Jan 24;(1):CD003510.
 Abstract
 
A Prospective Controlled Study of Neurodevelopment in HIV-Uninfected Children Exposed to
Combination Antiretroviral Drugs in Pregnancy.
Alimenti A, Forbes JC, Oberlander TF, et al
Pediatrics. 2006 Aug 28;
 Abstract
 
Longitudinal Relationships Between Use of Highly Active Antiretroviral Therapy and
Satisfaction With CareAmong Women Living With HIV/AIDS.
Burke-Miller JK, Cook JA, Cohen MH, et al
Am J Public Health. 2006 May 2;
 Abstract
 
A WEEK-IN-REVIEW FEATURED REPORT
Failure to eradicate HIV despite fully successful HAART initiated in the first days of life.
Vigano A, Trabattoni D, Schneider L,
Pediatr. 2006 Mar;148(3):389-91.
Abstract

Highly Active Antiretroviral Therapy Started during Pregnancy or Postpartum Suppresses
HIV-1 RNA, but Not DNA, in Breast Milk.
 Shapiro RL, Ndung’u T, Lockman S, et al  Infect Dis. 2005 Sep 1;192(5):713-9.
Abstract
 
Effect of antiretroviral agents on carbohydrate metabolism in HIV-1 infected pregnant women.
 Beitune PE, Duarte G, Foss MC, Montenegro RM Jr, et al 
Diabetes Metab Res Rev. 2005 Jul 15; 
Abstract 
 
Antiretroviral therapy and pregnancy
Wunder D, Evison JM.   
Ther Umsch. 2005 Jan;62(1):37-42
 Abstract 
 
Mother-to-Child Transmission of HIV Infection in the Era of Highly Active
Antiretroviral  Therapy.
European Collaborative Study.
Clin Infect Dis. 2005 Feb 1;40(3):458-465
 Abstract 
 
Decrease in Hospitalization and Mortality Rates among Children with Perinatally
Acquired HIV Type 1 Infection Receiving Highly Active Antiretroviral Therapy.
Viani RM, Araneta MR, Deville JG, Spector SA. et al
Clin Infect Dis. 2004 Sep 1;39(5):725-31.
 Abstract 

FULL-TEXT ARTICLE
 Women’s reasons for not participating in follow up visits before starting short
course antiretroviral prophylaxis for prevention of mother to child transmission
of HIV: qualitative interview study
Painter TM, Diaby KL, Matia DM, et al 
BMJ  2004;329:543
 Paper

Use of antiretroviral drugs to prevent HIV-1 transmission through breast-feeding:
from animal studies to randomized clinical trials.
Gaillard P, Fowler MG, Dabis F, et al   
J Acquir Immune Defic Syndr. 2004 Feb 1;35(2):178-87.
 Abstract 

Immunoprophylaxis to prevent mother-to-child transmission of HIV-1.
 Safrit JT, Ruprecht R, Ferrantelli F, et al   
J Acquir Immune Defic Syndr. 2004 Feb 1;35(2):169-77.
Abstract
 
Decision analysis to guide choice of interventions to reduce mother-to-child
transmission of HIV.
Bertolli J, Hu DJ, Nieburg P, et al.
AIDS. 2003 Sep 26;17(14):2089-98.
 Abstract
 
Human immunodeficiency virus and pregnancy.